Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Adbiotech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩3.2 K
2024-10-29
Market Capitalization
₩28.8 B
2024-10-29
Revenue
₩11.1 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|
| Revenue | 9.8B | 11.8B | 10.6B | 10.5B | 11.1B |
| Cost of goods sold | 3.8B | 5.6B | 6.2B | 6.6B | 6.5B |
| Gross profit | 6.1B | 6.2B | 4.5B | 3.9B | 4.8B |
| Gross profit margin, % | 61.8% | 52.4% | 42.1% | 36.9% | 43.4% |
| Operating expense total | 6.8B | 7.2B | 8.7B | 7.5B | 7.8B |
| Depreciation and amortization | 181.1M | 651.6M | 725.7M | 3.7B | 1.4B |
| EBITDA | (766.4M) | (993.5M) | (4.2B) | (3.6B) | (2.9B) |
| EBITDA margin, % | -7.8% | -8.4% | -39.6% | -34.6% | -26.3% |
| EBIT | (990.4M) | (1.7B) | (5.0B) | (7.7B) | (4.5B) |
| EBIT margin, % | -10.1% | -14.7% | -47.5% | -73.6% | -40.8% |
| Interest income | 9.6M | 5.7M | 158.2M | 149.7M | 76.5M |
| Interest expense | 579.5M | 130.2M | 124.7M | 426.4M | 682.1M |
| Pre tax profit | (7.5B) | (2.4B) | 2.7B | (5.5B) | (9.0B) |
| Income tax expense | (131.3M) | 249.8M | (25.6M) | (25.7M) | |
| Net Income | (7.3B) | (2.7B) | 2.7B | (5.4B) | (9.0B) |